Stryker Completes China Acquisition
Stryker has completed its landmark purchase of Jiangsu, China-based Trauson Holdings Company Ltd., a manufacturer of medical devices in the trauma and spine segments.
“With the acquisition of Trauson, we are well positioned to broaden our presence in China and to expand into the fast growing value segment of the emerging markets,” said Kevin A. Lobo, president and CEO. “We look forward to building on the company’s long history of success.”
Manufacturing in China for China (and the world) has become a very attractive proposition for medical device companies, but particularly those that make orthopedic devices. China is such a large market base, with a middle class numbering 350 million (approximately the entire population of the United States), and often requires orthopedic implants of a smaller size than is optimized for the American or European markets.
Stryker maintained that the acquisition will remain neutral to the company’s 2013 earning per share, excluding acquisition and integration-related costs.
Stryker’s main business is orthopedics, particularly spine and neurotechnology. The company provides medical devices in a range of segments, and is headquartered in Kalamazoo, Mich.